The above processes, combined with the antioxidant effect of the microgel system, inhibited activation of the NF‐κB‐NLRP3 pathway and inflammasome production in microglia, relieving neuroinflammation and pathological symptoms of PD. Here, NFKB1 is linked to Parkinson disease.